96 results
8-K
NEO
Neogenomics Inc.
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
the Company and that in connection with his retirement he was tendering his resignation as Executive Chairman and Chairman of the Board of the Company … Disclosure.
On October 12, 2021, the Company issued a press release announcing Mr. VanOort’s retirement as the Company’s Executive Chairman and Chairman
8-K
EX-99.1
NEO
Neogenomics Inc.
28 Jul 20
NeoGenomics Reports Revenue of $87 Million
8:18am
reimbursements received related to the CARES Act, cash flow hedge termination fees, debt retirement fees and other non-recurring items.
Reconciliation … to the CARES Act, cash flow hedge termination fees, debt retirement fees and other non-recurring items.
(5) This adjustment is for rounding and, in those
8-K
NEO
Neogenomics Inc.
10 Feb 11
NeoGenomics Announces Changes to its Board of Directors
12:00am
of public company boards of directors. From July 1998 until his retirement in June 2002, Mr. Hipp served as Chairman, President and CEO of Alternative
8-K
EX-99.1
i8lbnr0j 609wk8g68
10 Dec 18
Completion of Acquisition or Disposition of Assets
5:14pm
8-K
EX-99.1
br7hydfy0sgitp396s
27 Oct 20
NeoGenomics Reports Revenue Growth of 20% to Record $125 Million
7:59am
8-K
EX-3.1
w4a dyulsrr
17 Oct 14
Charter of the Compliance Committee
12:00am
8-K
EX-99.1
kbrhfwx5m00cqfhg5
10 Feb 11
NeoGenomics Announces Changes to its Board of Directors
12:00am
8-K
EX-99.1
ckdsirf5wbjrl p94
12 Oct 21
NeoGenomics Announces Board of Directors’ Transition
5:03pm
8-K
n2utmm86q9yt8cs4
11 May 22
NeoGenomics Announces Leadership Transition Appointing Vishal Sikri as President and Chief Commercial Officer of Inivata Liquid Biopsy Subsidiary
5:02pm
8-K
EX-99.1
4d3g2t 1c052f
6 Aug 21
NeoGenomics Reports 40% Revenue Growth to $122 Million
7:10am
8-K
EX-99.1
7kayk 501yazz3pa5n5
4 Nov 21
NeoGenomics Reports Revenue of $121 Million
7:23am
8-K
EX-99.1
zbn ts2gpt32tra
23 Feb 22
NeoGenomics Reports Full Year Revenue of $484 Million and Fourth Quarter Results
7:14am
8-K
EX-99.1
iwh1t5muya4j09 ss26r
7 Jun 07
Unregistered Sales of Equity Securities
12:00am
SB-2
bh1o 09muxm
28 Jul 06
Registration of securities for small business issuer
12:00am
POS AM
3rv 5cwf6jam4
5 Jul 06
Prospectus update (post-effective amendment)
12:00am
8-K
EX-10.1
g8wkk
28 Mar 22
NeoGenomics Announces CEO Departure and Initiates CEO Search
4:20pm
8-K
EX-99.1
h7xgt7j6hm17lu ubg
14 Apr 22
Other Events
4:23pm